Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER × eprenetapopt × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Terminated 1 Completed 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

Cyclophosphamide 238 Radiotherapy 215 Gemcitabine 186 Cisplatin 185 Carboplatin 181 Docetaxel 165 Bevacizumab 165 Paclitaxel 144 Capecitabine 141 Rituximab 140 pembrolizumab 137 Oxaliplatin 124 Dexamethasone 121 Nivolumab 120 Fluorouracil 113 fludarabine 102 Radiosurgery 99 Doxorubicin 99 Irinotecan 96 fludarabine phosphate 95 Etoposide 95 Lenalidomide 92 Radiation 89 Cytarabine 89 Leucovorin 88 Filgrastim 88 Magnetic Resonance Spectroscopy 87 Bortezomib 85 Temozolomide 78 Pemetrexed 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02999893 2021-12-13

APROC

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡